Analytical Data
-
Gene name
REG-2
- Application
-
Alternative Names
Regenerating Islet-derived 2; Islet of Langerhans regenerating protein 2; Pancreatic stone protein 2; Pancreatic thread protein 2; PSP; PTP
-
Species
Mouse
-
Source
HEK293
-
Tag
N-6*His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q08731
-
Expression Region
Q23-A173
-
Protein Length
Full Length of Mature Protein
-
Molecular Weight
16.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The BD-3 recombinant protein is a focus of research due to its potential applications in various biotechnological and therapeutic fields. BD-3, as a member of the bacteriocin family, demonstrates antimicrobial properties, particularly against a range of pathogenic bacteria. The growing concern over antibiotic resistance has heightened interest in alternative antimicrobial agents, making the exploration of bacteriocins like BD-3 particularly relevant. Researchers aim to better understand its structure, function, and interaction mechanisms at the molecular level. In vitro and in vivo studies have indicated that BD-3 exhibits not only bactericidal activity but also synergistic effects when used in combination with traditional antibiotics, enhancing their efficacy. Additionally, BD-3’s stability and efficacy at varying pH levels and temperatures mark it as a promising candidate for incorporation into food preservation and clinical applications. Given the urgent need for new antimicrobial strategies, the study of BD-3 recombinant protein may pave the way for innovative solutions to combat infectious diseases and address the global challenge of antibiotic resistance. This growing interest in BD-3 propels further investigation into its therapeutic potential, safety profile, and mechanisms of action, ultimately contributing to the development of novel antimicrobial drugs and enhancing food safety protocols.
